This finding parallels the CD34+CD38−/dim leukemic stem cell (LSC) phenotype observed in myeloproliferative neoplasms, since these LSCs are believed to initiate leukemia and play a pivotal role in disease relapse [42]. The gene discussed is CD38; the disease is myeloproliferative disorder.